A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

被引：0
|
作者：
M W Drummond
C Pocock
M Boissinot
J Mills
J Brown
P Cauchy
N C P Cross
S Hartley
J Kell
A Szubert
P N Cockerill
D T Bowen
机构：
[1] Beatson West of Scotland Cancer Centre and University of Glasgow,Department of Hematology
[2] East Kent Hospitals,Department of Hematology
[3] Leeds Institute for Cancer Studies and Pathology,Department of Hematology
[4] University of Leeds,undefined
[5] Worcestershire Acute Hospitals NHS Trust and University of Birmingham,undefined
[6] Clinical Trials Research Unit,undefined
[7] University of Leeds,undefined
[8] Institute of Biomedical Research,undefined
[9] University of Birmingham,undefined
[10] Faculty of Medicine,undefined
[11] University of Southampton,undefined
[12] University Hospital of Wales,undefined
[13] St James's Institute of Oncology,undefined
来源：
Leukemia | 2014年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1570 / 1572
页数：2
相关论文
共 50 条
  • [1] A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia
    Drummond, M. W.
    Pocock, C.
    Boissinot, M.
    Mills, J.
    Brown, J.
    Cauchy, P.
    Cross, N. C. P.
    Hartley, S.
    Kell, J.
    Szubert, A.
    Cockerill, P. N.
    Bowen, D. T.
    [J]. LEUKEMIA, 2014, 28 (07) : 1570 - 1572
  • [2] CMML201: A PHASE 2 TRIAL OF AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
    Drummond, W.
    Boissinot, M.
    Cauchy, P.
    Cross, N.
    Hartley, S.
    Kell, J.
    Pocock, C.
    Szubert, A.
    Brown, J.
    Cockerill, P.
    Bowen, D.
    [J]. HAEMATOLOGICA, 2012, 97 : 358 - 358
  • [3] Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia
    Tremblay, Douglas
    Shih, Alan
    Feld, Jonathan
    Moshier, Erin
    Mascarenhas, John
    [J]. BLOOD, 2023, 142
  • [4] Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
    Edlin, R.
    Connock, M.
    Tubeuf, S.
    Round, J.
    Fry-Smith, A.
    Hyde, C.
    Greenheld, W.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 69 - 74
  • [5] BROTIZOLAM AND CHRONIC INSOMNIA - A MULTI-CENTRE STUDY
    FRITZOSNER, A
    ARIASORTIZ, JL
    DORANTES, JF
    RABAGOSANCHEZ, J
    RODRIGUEZTENORIO, A
    SANCHEZMARTINEZ, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 : S413 - S414
  • [6] NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia
    Miller, Whitney
    Holden, Joanne
    George, Elisabeth
    Stein, Ken
    [J]. LANCET ONCOLOGY, 2011, 12 (04): : 326 - 327
  • [7] Predicting clinical outcome in early stage chronic lymphocytic leukaemia (CLL): A multi-centre study of 1153 patients
    Pepper, C.
    Majid, A.
    Len, T.
    Hewamana, S.
    Pratt, G.
    Wagner, S.
    Kennedy, D. B.
    Miall, F.
    Gesk, S.
    Siebert, R.
    Davis, Z.
    Tracey, I.
    Gardiner, A.
    Brennan, P.
    Dyer, M. J. S.
    Oscier, D. G.
    Fegan, C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 20 - 20
  • [8] Azacitidine/cisplatin/hydroxycarbamideMyelodysplastic/myeloproliferative neoplasm transformed into chronic myelomonocytic leukaemia and then acute myeloid leukaemia: case report
    [J]. Reactions Weekly, 2015, 1555 (1) : 28 - 28
  • [9] Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose- escalation, dose-expansion, phase 1-2 study
    Bazinet, Alexandre
    Darbaniyan, Faezeh
    Jabbour, Elias
    Montalban-Bravo, Guillermo
    Ohanian, Maro
    Chien, Kelly
    Kadia, Tapan
    Takahashi, Koichi
    Masarova, Lucia
    Short, Nicholas
    Alvarado, Yesid
    Yilmaz, Musa
    Ravandi, Farhad
    Andreeff, Michael
    Kanagal-Shamanna, Rashmi
    Ganan-Gomez, Irene
    Colla, Simona
    Qiao, Wei
    Huang, Xuelin
    McCue, Deborah
    Mirabella, Bailey
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    [J]. LANCET HAEMATOLOGY, 2022, 9 (10): : E756 - E765
  • [10] AZACITIDINE IN 'REAL LIFE' PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): A SINGLE CENTRE EXPERIENCE
    Tendas, A.
    Cupelli, L.
    Piccioni, D.
    Caravita, T.
    Siniscalchi, A.
    Del Poeta, G.
    Scaramucci, L.
    Giovannini, M.
    Dentamaro, T.
    Perrotti, A.
    Fratoni, S.
    de Fabritiis, P.
    Niscola, P.
    [J]. HAEMATOLOGICA, 2014, 99 : 621 - 622
12345